éå»1ã¶æéã«Iovance Biotherapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã10åã«åºã¥ãããŒã¿ã
仿ãIOVAã¯7ä»¶ã®ãè²·ããã2ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããIOVAã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯13.300ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -0.105ã«ç¶ããIOVAã®FY2026Q3ã®EPSã¯-0.085ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.11 ã§ããããIovance Biotherapeutics IncIOVA ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.19 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.09 ãšäºæ³ãããŸãã